In this current day and age, humans are living an average of thirty years longer than those in the previous century. What to do with all those extra years of living? In A LONG BRIGHT FUTURE, Laura Carstensen, the founding director of the Stanford Center on Longevity, has envisioned a new approach to life, one that allows us to put to best use the extra years we have gained. She calls for nothing less than a major reenvisioning of our life cycle, one that allows for more flexibility and leisure throughout our younger years and a more active, productive golden […]
In an article published online on October 12, 2011 in Science Translational Medicine Dr Robert Modlin and his colleagues at the University of California, Los Angeles report an essential role for vitamin D in the body’s ability to fight tuberculosis (TB).
A study reported in the journal Neurology reveals an association between olive oil consumption and a lower risk of stroke.* Cécilia Samieri, PhD, and her associates analyzed data from 7,625 participants in the Three-City Study.
Findings published in PLoS ONE demonstrate a protective effect for brief periods of exercise against stress-induced damage to telomeres: pieces of DNA that
The Journal of Nutrition reports a reduction in the risk of dying from coronary heart disease (CHD) among men and women who consumed high fiber diets.* Researchers evaluated data from 58,730 participants
At the annual meeting of the American Society of Clinical Oncology held in Chicago, researchers from the Mayo Clinic reported results from a Phase II trial which provide additional evidence of clinical activity and low toxicity for epigallocatechin gallate (EGCG, extracted from green tea) in chronic lymphocytic leukemia (CLL) patients.*
At the annual meeting of the American Society of Clinical Oncology held in Chicago, researchers from the Mayo Clinic reported results from a Phase II trial which provide additional evidence of clinical activity and low toxicity for epigallocatechin gallate (EGCG, extracted from green tea) in chronic lymphocytic leukemia (CLL) patients.* Hematologist Tait Shanafelt, MD and colleagues gave 2,000 milligrams EGCG to patients with early stage, asymptomatic CLL.







